A psilocin fungus, also known as a magic fungus or psychedelic fungus, is one of a polyphyletic group of fungi that contain psilocin and psilocin.
Biological genera containing psilocybin fungi include Pholiotina, Pluteus, and Psilocybe. Psilocybin mushrooms are used even nowadays in religious rites and ceremonies.
They can be described in rock art from the African and European stone eras, but are best known in pre-Columbian sculptures and glyphs seen thorough in Central and South America.
The effects of “magic” mushrooms come from psilocybin and psilocin. When psilocybin is ingested, it is broken down to produce psilocin, which is responsible for the psychedelic effects.
Psilocybin and psilocin create short-term increases in tolerance of users, thus making it difficult to abuse them because the more often they are taken within a short period, the weaker the resultant effects are.
Psilocybin mushrooms have not been known to cause physical or psychological dependence (addiction). The psychedelic effects tend to appear around 20 minutes after ingestion and will last approximately 6 hours.
Physical effects, including nausea, vomiting, muscle weakness, drowsiness, and lack of coordination, may also occur.
Magic Mushrooms Can Reduce Anxiety and Depression
Magic mushrooms are also used in experiments that are destined to cure cancer, and the results are pretty good for the moment. It’s known that psilocybin reduces the anxiety, depression, hopelessness, demoralization, and death anxiety after receiving the dose combined with psychotherapy.
Dr. Stephen Ross (associate professor of psychiatry in the Department of Psychiatry at NYU Langone Health) said: “Our findings strongly suggest that psilocybin therapy is a promising means of improving the emotional, psychological, and spiritual well-being of patients with life-threatening cancer.”
The results reported by the team in 2016, in which 29 patients with cancer-related anxiety and depression were tested by giving them either a dose of psilocybin. After almost two months, they were given “the antidote.”
This test was combined with nine sessions of psychotherapy. After six and a half months, all patients had received psilocybin, about 60% – 80%, showed reductions in depression, anxiety, and improved attitudes toward death.
Dr. Ross firmly believes that an alternative means treating anxiety and depression among cancer patients. He also claims that a third of people diagnosed with cancer will develop anxiety, depression, and other forms of distress.
The results build on growing evidence supporting the benefits of psilocybin on mental health. In 2018 were 18 million people over the world diagnosed with cancer and depression were more common among patients with cancer than the rest of the population.